Oxytocin Treatment in Neonates and Infants Aged From 0 to 3 Months With Prader-Willi Syndrome : a Study of Safety and Efficacy on Oral and Social Skills and Feeding Behavior of Intranasal Administration of Oxytocin vs Placebo
Latest Information Update: 01 Apr 2026
At a glance
- Drugs Oxytocin (Primary)
- Indications Prader-Willi syndrome
- Focus Therapeutic Use
Most Recent Events
- 01 Apr 2026 New trial record